Ad is loading...
GVCCX
Price
$7.13
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
VIMAX
Price
$339.21
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

GVCCX vs VIMAX

Header iconGVCCX vs VIMAX Comparison
Open Charts GVCCX vs VIMAXBanner chart's image
Gabelli Value 25 C
Price$7.13
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$339.21
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
GVCCX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVCCX vs. VIMAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCCX is a Buy and VIMAX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 175B vs. GVCCX (219M). VIMAX pays higher dividends than GVCCX: VIMAX (1.49) vs GVCCX (0.00). GVCCX was incepted earlier than VIMAX: GVCCX (25 years) vs VIMAX (23 years). VIMAX is a more actively managed with annual turnover of: 13.00 vs. GVCCX (6.00). GVCCX has a lower initial minimum investment than VIMAX: GVCCX (1000) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 28.56 vs. GVCCX (9.34). VIMAX return over 5 years is better than : 59.92 vs. GVCCX (-35.39).
GVCCXVIMAXGVCCX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years23 years-
Gain YTD13.69417.99676%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets219M175B0%
Annual Yield % from dividends0.001.49-
Returns for 1 year9.3428.5633%
Returns for 3 years-34.926.30-554%
Returns for 5 years-35.3959.92-59%
Returns for 10 years-58.09130.76-44%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JAKK28.38-0.15
-0.53%
JAKKS Pacific
UMH19.54-0.21
-1.06%
UMH Properties
SANM77.65-0.94
-1.20%
Sanmina Corp
ATHA0.71-0.02
-2.22%
Athira Pharma
VRT121.03-3.50
-2.81%
Vertiv Holdings Co